Mirum Pharmaceuticals MIRM
NASDAQ MIRM
$81.84 -2.08 (-2.48%)
As of: Oct 2, 2026 · 12:23 PM EDT

Mirum Pharmaceuticals (MIRM) Accumulated Expenses (2018 - 2026)

Updated

Mirum Pharmaceuticals (MIRM) reported Accumulated Expenses of $174.56 million for Q2 2026, up 37.3% from $127.14 million a year earlier but down 7.0% from the prior quarter.

Analysis

Mirum Pharmaceuticals (MIRM) Accumulated Expenses (2018 - 2026) Analysis & Trends

At the end of FY2025, Mirum Pharmaceuticals posted Accumulated Expenses of $196.19 million, up 75.3% from FY2024.

  • Accumulated Expenses has increased for seven consecutive years, with a five-year compound annual growth rate of 71.0% (FY2020 to FY2025).
  • By year, Accumulated Expenses came in at $111.93 million in FY2024 (+42.5%), $78.54 million in FY2023 (+45.4%), $54.02 million in FY2022 (+75.8%) and $30.72 million in FY2021 (+129.1%).
  • Five-year quarterly Accumulated Expenses spans a low of $26.88 million in Q1 2022 and a high of $196.19 million in Q4 2025.
  • Year over year, Accumulated Expenses has now increased in each of the last 15 quarters, with growth averaging 46.4% over the last eight quarters.
  • The high point for year-over-year Accumulated Expenses in five years was Q3 2021 (growth of 237.3%); the low point was Q3 2022 (a decline of 12.6%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $187.63 million (Q1 2026), $196.19 million (Q4 2025) and $148.19 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Mirum Pharmaceuticals 5.54 Bn 3.95 Bn 145.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 174.56 Mn
Mar 31, 2026 187.63 Mn
Dec 31, 2025 196.19 Mn
Sep 30, 2025 148.19 Mn
Jun 30, 2025 127.14 Mn
Mar 31, 2025 115.94 Mn
Dec 31, 2024 111.93 Mn
Sep 30, 2024 104.70 Mn
Jun 30, 2024 101.39 Mn
Mar 31, 2024 89.57 Mn
Dec 31, 2023 78.54 Mn
Sep 30, 2023 66.21 Mn
Jun 30, 2023 42.69 Mn
Mar 31, 2023 40.40 Mn
Dec 31, 2022 54.02 Mn
Sep 30, 2022 38.31 Mn
Jun 30, 2022 34.54 Mn
Mar 31, 2022 26.88 Mn
Dec 31, 2021 30.72 Mn
Sep 30, 2021 43.85 Mn
API Access

Mirum Pharmaceuticals Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=MIRM&period=max&api_key=YOUR_API_KEY